Publications of Olaf Jahn
All genres
Journal Article (122)
101.
Journal Article
8 (1), pp. 6 - 9 (2007)
Automatisierter Protein-In-Gel-Verdau für MALDI-TOF-MS. Laborwelt 102.
Journal Article
386 (1), pp. 92 - 103 (2006)
Technical innovations for the automated identification of gel-separated proteins by MALDI-TOF mass spectrometry. Analytical and Bioanalytical Chemistry 103.
Journal Article
141 (1), pp. 47 - 60 (2006)
Identification and characterization of a stress-inducible and a constitutive small heat-shock protein targeted to the matrix of plant peroxisomes. Plant Physiology 104.
Journal Article
1763, pp. 1256 - 1265 (2006)
Characterization of the Munc13-calmodulin interaction by photoaffinity labeling. Biochimica et Biophysica Acta 105.
Journal Article
12, pp. 44 - 45 (2006)
Automatisierter Protein-In-Gel-Verdau für MALDI-TOF-MS. Transkript 106.
Journal Article
5 (10), pp. 953 - 960 (2005)
Corticotropin-releasing factor binding protein - A ligand trap? Mini-Reviews in Medicinal Chemistry 107.
Journal Article
312 (3), pp. 905 - 916 (2005)
Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear. Journal of Pharmacology and Experimental Therapeutics 108.
Journal Article
25 (4), pp. 1339 - 1346 (2005)
Unchanged Survival Rates of 14-3-3γ Knockout Mice after Inoculation with Pathological Prion Protein. Molecular and Cellular Biology 109.
Journal Article
29 (8), pp. 1323 - 1333 (2005)
The role of CRF receptors in anxiety and depression: Implications of the novel CRF1 agonist cortagine. Neuroscience & Biobehavioral Reviews 110.
Journal Article
118 (3), pp. 389 - 401 (2004)
Calmodulin and Munc13 form a Ca2+ sensor/effector complex that controls short-term synaptic plasticity. Cell 111.
Journal Article
47 (2), pp. 233 - 242 (2004)
Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity. Neuropharmacology 112.
Journal Article
101 (25), pp. 9468 - 9473 (2004)
Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proceedings of the National Academy of Sciences of the United States of America 113.
Journal Article
378, 10.1007/b11962, pp. 1031 - 1036 (2003)
Characterization of peptide-protein interactions using photoaffinity labeling and LC/MS. Analytical and Bioanalytical Chemistry 114.
Journal Article
228, pp. 527 - 540 (2003)
Tandem mass spectrometric characterization of branched peptides derived from photoaffinity labeling. International Journal of Mass Spectrometry 115.
Journal Article
99 (19), pp. 12055 - 12060 (2002)
The binding protein of corticotropin-releasing factor: Ligand- binding site and subunit structure. Proceedings of the National Academy of Sciences of the United States of America 116.
Journal Article
23 (5), pp. 881 - 888 (2002)
Differential responsiveness of CRF receptor subtypes to N- terminal truncation of peptidic ligands. Peptides 117.
Journal Article
214 (1), pp. 37 - 51 (2002)
The use of multiple ion chromatograms in on-line HPLC-MS for the characterization of post-translational and chemical modifications of proteins. International Journal of Mass Spectrometry 118.
Journal Article
8 (3-4 Sp. Iss. SI), pp. 163 - 177 (2002)
Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors and Channels 119.
Journal Article
98 (20), pp. 11142 - 11147 (2001)
A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists. Proc. Natl. Acad. Sci. U. S. A. 120.
Journal Article
10, pp. 2050 - 2062 (2001)
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Science